Results 161 to 170 of about 6,828 (196)

Micropulse Cyclophotocoagulation: Initial Results in Refractory Glaucoma

open access: yesJournal of Glaucoma, 2017
Purpose: The purpose of this study is to evaluate the use of micropulse transscleral cyclophotocoagulation (MP-TSCPC), a new and increasingly popular treatment, in patients with uncontrolled glaucoma. Methods: A retrospective chart ...
Matthew E. Emanuel   +8 more
semanticscholar   +4 more sources

First experience using micropulse cyclophotocoagulation in complex treatment acute angle closure glaucoma

open access: yesRussian Ophthalmological Journal, 2021
Purpose. To study effectiveness of micropulse cyclophotocoagulation (MP-CPC) in complex treatment acute angle closure glaucoma (ACG). Material and methods. Dynamic observation of 4 patients with acute ACG was carried out.
V. Egorov   +3 more
semanticscholar   +5 more sources

Efficiency of micropulse cyclophotocoagulation in treatment of refractory glaucoma

open access: yesModern technologies in ophtalmology, 2022
Purpose. To evaluate the clinical efficacy of micropulse cyclophotocoagulation (mCPC) in the treatment of patients with grade III refractory glaucoma. Material and methods.
V. Egorov   +2 more
semanticscholar   +2 more sources

Hyphema and vitreous hemorrhage after micropulse cyclophotocoagulation a case report

European Journal of Ophthalmology
Introduction We present two cases of vitreous hemorrhage after micropulse cyclophotocoagulation one of which had concurrent hyphema. To the best of our knowledge, these are the first cases of vitreous hemorrhage due to micropulse CPC in the United States.
Megh K. Shah   +3 more
semanticscholar   +3 more sources

Update on Micropulse Transscleral Cyclophotocoagulation

Journal of Glaucoma, 2020
Micropulse transscleral cyclophotocoagulation is a promising and relatively new technique that uses repetitive micropulses of diode laser energy, delivered with the Cyclo G6 Glaucoma Laser System (Iridex Corporation), in an off-and-on cyclical manner.
Facundo G, Sanchez   +4 more
openaire   +2 more sources

MicroPulse™ Transscleral Cyclophotocoagulation in the Treatment of Canine Glaucoma: Preliminary Results (12 Dogs) [PDF]

open access: yesVeterinary Ophthalmology, 2019
Objective: To describe the clinical application and effect of MicroPulse™ transscleral cyclophotocoagulation (MP‐TSCPC) in dogs with glaucoma. Animals studied: Twelve dogs with primary (n = 8) or secondary (n = 4) glaucoma, aged 2‐13 years (mean ± SD ...
Rachell A Allbaugh   +2 more
exaly   +1 more source

Micropulse Transscleral Cyclophotocoagulation as Primary Surgical Treatment for Primary Open Angle Glaucoma in Taiwan During the COVID-19 Pandemic

open access: yesHealthcare, 2021
[[abstract]]Glaucoma is the leading cause of irreversible blindness worldwide, with primary open angle glaucoma (POAG) accounting for the greatest number of total glaucoma cases.
Hung-Yu Lin   +2 more
exaly   +2 more sources

Micropulse Transscleral Cyclophotocoagulation in Keratoplasty Eyes

Cornea, 2019
Purpose: To assess the outcomes of micropulse transscleral cyclophotocoagulation for intraocular pressure (IOP) control in keratoplasty eyes. Methods: Outcomes of micropulse laser treatments of postkeratoplasty eyes were retrospectively reviewed.
Kavitha, Subramaniam   +3 more
openaire   +2 more sources

Real-world outcomes of micropulse cyclophotocoagulation in a latin american population and analysis of the factors associated with the success rate.

Archivos de la Sociedad Española de Oftalmología, 2022
OBJECTIVE To report the outcomes of micropulse cyclophotocoagulation in a Latin American population with refractory glaucoma in a "real-world" setting and to evaluate the factors associated with success after a one-year follow-up.
C. Prado-Larrea   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy